Business
Press Release Aug 05 2020
Alkem Laboratories Limited has informed the Exchange regarding a press release dated August 05, 2020, titled "ALKEM launches Favipiravir in India under the brand name Alfluenza for the treatment of mild to moderate COVID-19.".
About this update from Alkem Laboratories Ltd.
[{"type":"text","content":" Alkem Laboratories Limited has informed the Exchange regarding a press release dated August 05, 2020, titled \"ALKEM launches Favipiravir in India under the brand name Alfluenza for the treatment of mild to moderate COVID-19.\". View Attachment","length":388,"tagName":"div"}]